Surgical treatment of ulcers caused by extravasation of cytotoxic drugs

Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery

Volumn 38, Issue 5, 2004, Pages 288-292

  D'Andrea, Francesco ^a,c   Onesti, Maria Giuseppina ^b   Nicoletti, Giovanni Francesco ^a   Grella, Elisa ^a   Renzi, Luca Francesco ^b   Spalvieri, Cristina ^b   Scuderi, Nicolò ^b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c NONE   (Italy)

Author keywords

Cytotoxic drugs; Extravasation ulcer; Surgical therapy

Indexed keywords

CYTOTOXIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CHILD; CLINICAL PROTOCOL; EXTRAVASATION; FEMALE; FOLLOW UP; FREE TISSUE GRAFT; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE FLAP; SKIN GRAFT; TISSUE NECROSIS; TREATMENT OUTCOME; ULCER;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; COHORT STUDIES; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SKIN TRANSPLANTATION; SKIN ULCER; SURGICAL FLAPS; TREATMENT OUTCOME; UPPER EXTREMITY; WOUND HEALING;

EID: 8544249137     PISSN: 02844311     EISSN: None     Source Type: Journal    
DOI: 10.1080/02844310410027383     Document Type: Article

References (31)

1. Abbes M, Picard JL, Bourgeon Y et al. A propos des quarante et une complications locales de chemioterapie. (About fourty one local chemotherapeutic complications.) Ann Chir Plast Esthet 1986; 31: 149-156.
2. Bairey O, Bishara J, Stahl B, Shaklai M. Severe tissue necrosis after cisplatin extravasation at low concentration: possible immediate recall phenomenon. J Natl Cancer Inst 1997; 89: 1233-1239.
3. Banierjee A, Brotherston TM, Lamberty BGH et al. Cancer chemotherapy agent-induced perivenous extravasation injuries. Postgrad Med J 1987; 63: 5-9.
4. Bertelli G, Gozza A, Forno GB. Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: a prospective clinical study. J Clin Oncol 1995; 13: 2851-2855.
5. Bertelli G. Prevention and management of extravasation of cytotoxic drugs. Drug Saf 1995; 12: 245-255.
6. Bowers D Jr, Lynch JB. Adriamicin extravasation. Plast Reconstr Surg 1978; 1: 61-66.
7. Cohen FJ, Manganaro J, Bezozo RC. Identification of involved tissue during surgical treatment of doxorubicin-induced extravasation necrosis. J Hand Surg 1983; 8: 43-45.
8. Cohen FJ. Antineoplastic drug extravasation. Plast Reconstr Surg 1986; 77: 498-499.
9. Coleman JJ, Walker AP, Didolkar M. Treatment of adriamicin-induced skin ulcers: a prospective controlled study. J Surg Oncol 1983; 22: 129-134.
10. Cox K, Stuart Harris R, Abdini G et al. The management of cytotoxic-drug extravasation: guidelines drawn up by a working party for the Clinica Oncological Society of Australia. Med J Aust 1988; 148: 185-189.
11. Dorr RT, Albert DS, Stone A. Cold protection and heat enhancement of doxorubicin skin toxicity in the mouse. Cancer Treat Rep 1985; 69: 431-437.
12. Heckler FR. Current thoughts on extravasation injuries. Clin Plast Surg 1989; 16: 557-562.
13. Kjarkegaad K, Chenoufi H, Daugaard S. Fluorescence microscopic demonstration and demarcation of doxorubicin extravasation. Cancer 1990; 65: 1722-1726.
14. Larson DL. Alterations in wound healing secondary to infusion injury. Clin Plast Surg 1990; 17: 509-517.
15. Larson DL. What is the appropriate management of tissue extravasation by antitumor agents? Plast Reconstr Surg 1985; 75: 397-399.
16. Loth TS, Eversmann WW. Treatment methods for extravasation of chemotherapeutic agents: a comparative study. J Hand Surg 1986; 11A: 388-396.
17. Lucero MJ, Vigo J, Rabasco AM, Sanchez JA, Martin F. Protection by alpha-tocopherol against skin necrosis induced by doxorubicin hydrochloride. Pharmazie 1993; 48: 772-775.
18. Morykwas MJ, Kennedy A, Argenta JP, Argenta LC. Use of subatmospheric pressure to prevent doxorubicin extravasation ulcers in a swine model. J Surg Oncol 1999; 72: 14-17.
19. Onesti MG, Latini C, Amaturo R, Scuderi N. Lo stravaso di farmaci antiblastici come trauma del dorso della mano: protocollo di trattamento. (Extravasation of cytotoxic drugs in the dorsum of the hand: protocol of treatment.) Riv It Chir Plast 1993; 25: 229-232.
20. Pitkanen J, Asko-Seljavaara S, Grohn P. Adriamicin extravasation: surgical treatment and possible prevention of skin and soft tissue injuries. J Surg Oncol 1983; 23: 259-262.
21. Preuss P, Partoft S. Cytostatic extravasation. Ann Plast Surg 1987; 19: 323-327.
22. Rudolph R, Larson DL. Etiology and treatment of chemotherapeutic agent extravasation injuries: a review. J Clin Oncol 1987; 5: 1116-1119.
23. Scuderi N, Onesti MG. Antitumor agents: extravasation, management, and surgical treatment. Ann Plast Surg 1994; 32: 39-44.
24. Sonneveld P, Wassenaar HA, Nooter K. Long persistence of doxorubicin in human skin after extravasation. Cancer Treat Rep 1984; 68: 895-896.
25. Tsavaris NB, Karagiaouris P, Tzannou I et al. Conservative approach to the treatment of chemotherapy-induced extravasation. Dermatol Surg Oncol 1990; 16: 519-522.
26. Tsavaris NB, Karagiaouris P. Prevention of tissue necrosis due to accidental extravasation of cytostatic drugs by a conservative approach. Cancer Chemother Pharmacol 1992; 30: 330-333.
27. Van Sloten Harwood K, Aisner J. Treatment of chemotherapy extravasation: current status. Cancer Treat Rep 1984; 7: 939-945.
28. Vandeweyer E, Deraemecker R. Early surgical suction and washout for treatment of cytotoxic drug extravasations. Acta Chir Belg 2000; 100: 37-38.
29. Vandeweyer E, Heymans O, Deraemecker R. Extravasation injuries and emergency suction as treatment. Plast Reconstr Surg 2000; 105: 109-110.
30. Von Heimburg D, Pallua N. Early and late treatment of iatrogenic injection damage. Chirurg 1998; 69: 1378-1382.
31. Woods LS, Gullo SM. How to avoid extravasation. Am J Nurs 1993; 93: 42-46.